Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vaia Florou

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2026
Multi-Omic Landscape of Gastrointestinal Stromal Tumors in a Real-World Patient Cohort of 1,427 CasesCésar Serrano, Andrew Elliott, David Gómez-Peregrina, et al.
Research in Nursing & Health|May 26, 2026
Distinct Symptom Occurrence Subgroups Among Patients With Colorectal Cancer: Differences in Social Determinants of Health and Diet QualityYouran Lee, Qing Yang, Melissa Kay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2026
Efficacy and Tolerability of Zenocutuzumab in Advanced <i>NRG1</i> Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II TrialJames M Cleary, Christoph Springfeld, Dirk Arnold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2025
Large-Scale Multiomic Analysis Identifies Anatomic Differences and Immunogenic Potential in Subtypes of LeiomyosarcomaGalina Lagos, Roman Groisberg, Andrew Elliott, et al.
Cancer Medicine|November 26, 2024
Fusobacterium nucleatum Abundance is Associated with Cachexia in Colorectal Cancer Patients: The ColoCare StudyMmadili N Ilozumba, Tengda Lin, Sheetal Hardikar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2019
Clinical and Immunological Implications of Frameshift Mutations in Lung CancerYoung Kwang Chae, Pedro Viveiros, Gilberto Lopes, et al.
Journal for Immunotherapy of Cancer|March 3, 2021
Considerations for treatment duration in responders to immune checkpoint inhibitorsThomas U Marron, Aideen E Ryan, Sangeetha M Reddy, et al.
Journal of the Academy of Nutrition and Dietetics|April 1, 2026
Dietary patterns associated with weight loss among patients with colorectal cancer during the first six months post-diagnosis: A cross-sectional analysis from the ColoCare StudyRachel Hoobler, Fred K Tabung, Tengda Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancerThatcher Ross Heumann, Jiayun Lu, Hao Wang, et al.
Cancer Research Communications|August 23, 2024
ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid TumorsChristopher T Chen, Vishesh Khanna, Shivaani Kummar, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2026
Multi-Omic Landscape of Gastrointestinal Stromal Tumors in a Real-World Patient Cohort of 1,427 CasesCésar Serrano, Andrew Elliott, David Gómez-Peregrina, et al.
Research in Nursing & Health|May 26, 2026
Distinct Symptom Occurrence Subgroups Among Patients With Colorectal Cancer: Differences in Social Determinants of Health and Diet QualityYouran Lee, Qing Yang, Melissa Kay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2026
Efficacy and Tolerability of Zenocutuzumab in Advanced <i>NRG1</i> Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II TrialJames M Cleary, Christoph Springfeld, Dirk Arnold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2025
Large-Scale Multiomic Analysis Identifies Anatomic Differences and Immunogenic Potential in Subtypes of LeiomyosarcomaGalina Lagos, Roman Groisberg, Andrew Elliott, et al.
Cancer Medicine|November 26, 2024
Fusobacterium nucleatum Abundance is Associated with Cachexia in Colorectal Cancer Patients: The ColoCare StudyMmadili N Ilozumba, Tengda Lin, Sheetal Hardikar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2019
Clinical and Immunological Implications of Frameshift Mutations in Lung CancerYoung Kwang Chae, Pedro Viveiros, Gilberto Lopes, et al.
Journal for Immunotherapy of Cancer|March 3, 2021
Considerations for treatment duration in responders to immune checkpoint inhibitorsThomas U Marron, Aideen E Ryan, Sangeetha M Reddy, et al.
Journal of the Academy of Nutrition and Dietetics|April 1, 2026
Dietary patterns associated with weight loss among patients with colorectal cancer during the first six months post-diagnosis: A cross-sectional analysis from the ColoCare StudyRachel Hoobler, Fred K Tabung, Tengda Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancerThatcher Ross Heumann, Jiayun Lu, Hao Wang, et al.
Cancer Research Communications|August 23, 2024
ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid TumorsChristopher T Chen, Vishesh Khanna, Shivaani Kummar, et al.
Pageof 6